Quarterly report [Sections 13 or 15(d)]

Segment Information (Tables)

v3.26.1
Segment Information (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Segment Information The following table presents segment information for the periods presented (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2026 2025 2026 2025
Total Revenues $ 78,703  $ 101,685  $ 137,521  $ 155,018 
Less:
Employee related expenses 23,430  18,581  44,432  38,119 
Commercial related expenses 7,084  7,273  14,124  12,612 
Outside clinical trial related expenses 7,409  3,232  14,336  7,603 
Cost of product sales 8,525  4,504  13,131  8,913 
Consultants and third-party services 4,225  3,209  8,231  6,618 
Other segment items 4,455  3,783  7,807  7,277 
Interest (income) expense and other, net (10) 1,121  218  2,383 
Provision for income taxes 6,295  369  9,298  434 
Segment income $ 17,290  $ 59,613  $ 25,944  $ 71,059